Vanda Pharmaceuticals Incis A Biopharmaceutical Company Based In Washingtond C Focused On Developing Therapies For Central Nervous Systemcnsdisordersfounded In The Early 2000S By Ceo Mihales Polymeropoulosthe Company Collaborates With Investors Such As Care Capital Llc And Bio One Capital To Address Unmet Medical Needs Through Genetics And Genomics Vanda S Product Lineup Includes Hetliozwhich Treats Non 24 Hour Sleep Wake Disorderand Fanaptan Atypical Antipsychotic For Schizophreniathe Company Is Also Advancing Tradipitantan Investigational Treatment For Gastroparesiscurrently In Phase Iii Trialswith A Strong Commitment To Research And Developmentvanda Has Conducted Over 70 Clinical Trials And Continues To Explore New Treatments For Conditions Like Cystic Fibrosisthe Company Employs Around 350 Staff And Emphasizes Patient Centric Innovation In Its Approach To Drug Discovery And Clinical Development
No conferences found for this company.
| Company Name | Vanda Pharmaceuticals Germany Gmbh |
| Country |
Germany
|
| Address | N/A |
| Telephone | N/A |
| N/A |
